Evolutionary Genomics, Inc. Deferred Income Tax Expense (Benefit)
Evolutionary Genomics, Inc. reported Deferred Income Tax Expense (Benefit) of -$987.35 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2022-03-22
- Evolutionary Genomics, Inc. deferred income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
- Evolutionary Genomics, Inc. deferred income tax expense (benefit) for fiscal 2020 was -$987.35K, a 3194.47% decline from fiscal 2019.
- Evolutionary Genomics, Inc. deferred income tax expense (benefit) for fiscal 2019 was $31.91K.
- Evolutionary Genomics, Inc. deferred income tax expense (benefit) for fiscal 2017 was -$530.24K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$987.35K 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$987.35K 10-Q · filed 2021-11-01 | ||
| 2019-12-31 | $31.91K 10-K · filed 2021-03-31 | ||
| 2017-12-31 | -$530.24K 10-K · filed 2019-04-01 |